Patent 11738124

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

Active provider: Google · gemini-2.5-pro

PTAB activity (1)

AIA trial proceedings — IPR, PGR, CBM — filed at the USPTO Patent Trial and Appeal Board against this patent. Sourced directly from the PTAB Trial API.

  • IPR2025-01374IPRfiled Aug 4, 2025vs. Terumo BCT, Inc.Institution Denied

Cached for 24 hours. Status strings are sourced verbatim from the PTAB API; the colored badge is our heuristic classification.

Cases on file (2)

Group view →

Specific litigation cases in our database that name US patent 11738124. The free-form analysis below may also discuss cases beyond this list.

Litigation summary

Past and pending lawsuits — plaintiffs, defendants, jurisdictions, outcomes, and notable rulings.

✓ Generated

Litigation Surrounding US Patent 11,738,124 for Plasma Collection Technology

As of April 26, 2026, US patent 11,738,124, assigned to Haemonetics Corporation, is the subject of at least two legal challenges: a patent infringement lawsuit in federal district court and an Inter Partes Review (IPR) proceeding before the Patent Trial and Appeal Board (PTAB).

District Court Litigation:

Haemonetics Corporation has asserted its rights under the '124 patent in a lawsuit filed in the United States District Court for the District of Colorado.

  • Plaintiff: Haemonetics Corporation
  • Defendant: Terumo BCT, Inc.
  • Jurisdiction: U.S. District Court for the District of Colorado
  • Case Number: 1:25-cv-01409
  • Filing Date: May 5, 2025
  • Status: Active. The suit alleges patent infringement by Terumo BCT.

Patent Trial and Appeal Board (PTAB) Proceeding:

In addition to the district court case, the validity of US patent 11,738,124 is being challenged at the U.S. Patent and Trademark Office's Patent Trial and Appeal Board.

  • Petitioner: Terumo BCT, Inc.
  • Patent Owner: Haemonetics Corporation
  • Jurisdiction: USPTO Patent Trial and Appeal Board
  • Case Number: IPR2025-01374
  • Filing Date: August 4, 2025
  • Status: The PTAB instituted the Inter Partes Review on January 27, 2026, indicating that the petitioner, Terumo BCT, Inc., established a reasonable likelihood that it would prevail with respect to at least one of the claims challenged in the petition. The proceeding is currently pending before the board.

Generated 5/13/2026, 12:21:36 AM